Craft

Baxter International

Stock Price

$35.7

2024-05-10

Market Capitalization

$20.4 B

2024-04-27

Revenue

$14.8 B

FY, 2023

Baxter International Summary

Company Summary

Overview
Baxter International is a provider of primary care, kidney, nutritional, respiratory, hospital, and surgical care products. It offers acute and chronic dialysis therapies, sterile intravenous solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, advanced surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. The company serves hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, and other organizations.
Type
Public
Status
Active
Founded
1931
HQ
Deerfield, IL, US | view all locations
Website
https://www.baxter.com/
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • ​​José  E. Almeida

    ​​José E. Almeida, ​Chairman, President and Chief Executive Officer

  • Jeanne Mason

    Jeanne Mason, ​Executive Vice President and Chief Human Resources Officer

  • Talvis Love

    Talvis Love, Senior Vice President and Chief Information Officer

  • Tobi Karchmer

    Tobi Karchmer, Senior Vice President and Chief Medical & Scientific Officer

Operating MetricsView all

Manufacturing Facilities Leased

22
31.3%

FY, 2022

Distribution Facilities

66
48.0%

FY, 2022

Countries (Manufacturing Sites)

20

FY, 2022

LocationsView all

72 locations detected

  • Deerfield, IL HQ

    United States

    1 Baxter Pkwy

  • Marion, NC

    United States

    65 Pitts Station Rd

  • Opelika, AL

    United States

    1101 Jeter Ave

  • Round Lake, IL

    United States

    25212 IL-120

  • Old Toongabbie, NSW

    Australia

    1 Baxter Dr

  • Wien, Wien

    Austria

    Stella-Klein-Löw-Weg 15

and 66 others

Baxter International Financials

Summary Financials

Revenue (Q1, 2024)
$3.6B
Gross profit (Q1, 2024)
$1.4B
Net income (Q1, 2024)
$39.0M
Cash (Q1, 2024)
$3.0B
EBIT (Q1, 2024)
$187.0M
Enterprise value
$31.1B

Blogs

Footer menu